Proteinuria Reduction as a Surrogate Marker in IgA Nephropathy Clinical Trials

The goal of this podcast is to discuss the evidence that supports proteinuria reduction as a surrogate marker in IgA Nephropathy clinical trials.

Join NephU today at no cost for access to this and other premium content!

We’re collaborating to improve care and the future outcomes for individuals with kidney disease and other related conditions. NephU is a growing community where nephrology health care professionals engage, collaborate, and utilize resources to help improve future outcomes for those with kidney disease and other related conditions.

Join Today for Instant Access to all NephU Offerings.

Membership is free!